Author:
Frechette Dominique,Paquet Lise,Verma Shailendra,Clemons Mark,Wheatley-Price Paul,Gertler Stan Z.,Song Xinni,Graham Nadine,Dent Susan
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ, American Society of Clinical Oncology (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28(23):3784–3796
2. National Comprehensive Cancer Network (2010) National Comprehensive Cancer Network: Clinical practice guidelines in breast cancer, version1 http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
3. Fallowfield L (2011) Identification and management of treatment-related symptoms for breast cancer patients receiving adjuvant endocrine therapy. Eur J Cancer 47(Suppl 1):S80–S80
4. Bradford A (2013) Sexual outcomes of aromatase inhibitor therapy in women with breast cancer: time for intervention. Menopause 20(2):128–129
5. Goss PE, Ingle JN, Pritchard KI, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Johnson DB, Tozer R, D’Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Liedke PE, Lang I, Elliott C, Gelmon KA, Chapman JA, Shepherd LE (2013) Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27—a randomized controlled phase III trial. J Clin Oncol 31(11):1398–1404
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献